Sara Nuovo

Sara Nuovo

Auto-generated profile, based on publicly available information

Sara Nuovo

Neurogenetics Unit, IRCCS Santa Lucia Foundation, Rome, Italy

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2015 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
MWMary C Whitman
Mary C Whitman
CACaroline Andrews
Caroline Andrews
WCWai‐Man Chan
Wai‐Man Chan
MTMax A. Tischfield
Max A. Tischfield
SSSteven F. Stasheff
Steven F. Stasheff
EEElizabeth C Engle
Elizabeth C Engle

1 October 2017 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
RMRoberta De Mori
Roberta De Mori
MRMarta Romani
Marta Romani
SDStefano D’aRrigo
Stefano D’aRrigo
MZMaha S. Zaki
Maha S. Zaki
ELElisa Lorefice
Elisa Lorefice
EVEnza Maria Valente
Enza Maria Valente

4 July 2017 in European Radiology
Verified
Journal Article
Closed access
PDF file
RRRomina Romaniello
Romina Romaniello
FAFilippo Arrigoni
Filippo Arrigoni
EPELENA PANZERI
ELENA PANZERI
APAndrea Poretti
Andrea Poretti
AMAlessia Micalizzi
Alessia Micalizzi
RBRenato Borgatti
Renato Borgatti

25 February 2020 in Neurology
Verified
Journal Article
Open access
PDF file
SNSara Nuovo
Sara Nuovo
IBIlaria Bacigalupo
Ilaria Bacigalupo
MGMonia Ginevrino
Monia Ginevrino
RBRoberta Battini
Roberta Battini
EBEnrico Bertini
Enrico Bertini
OGon behalf of the JS Italian Study Group
on behalf of the JS Italian Study Group
Objective To estimate the prevalence of Joubert syndrome (JS) in Italy applying standards of descriptive epidemiology and to provide a molecular characterization of the described patient cohort. Methods We enrolled all patients with a neuroradiologically confirmed diagnosis of JS who resided in Italy in 2018 and calculated age and sex prevalence, assuming a Poisson distribution. We also investigated the correlation between proband chronological age and age at diagnosis and performed next-generation sequencing (NGS) analysis on probands9 DNA when available. Results We identified 284 patients with JS: the overall, female- and male-specific population-based prevalence rates were 0.47 (95% confidence interval [CI] 0.41–0.53), 0.41 (95% CI 0.32–0.49), and 0.53 (95% CI 0.45–0.61) per 100,000 population, respectively. When we considered only patients in the age range from 0 to 19 years, the corresponding population-based prevalence rates rose to 1.7 (95% CI 1.49–1.97), 1.62 (95% CI 1.31–1.99), and 1.80 (95% CI 1.49–2.18) per 100,000 population. NGS analysis allowed identifying the genetic cause in 131 of 219 screened probands. Age at diagnosis was available for 223 probands, with a mean of 6.67 ± 8.10 years, and showed a statistically significant linear relationship with chronological age (r2 = 0.79; p < 0.001). Conclusions We estimated for the first time the age and sex prevalence of JS in Italy and investigated the patients’ genetic profile. The obtained population-based prevalence rate was ≈10 times higher than that available in literature for children population.

21 October 2021 in Journal of Medical Genetics
Verified
Journal Article
Open access
PDF file
VSValentina Serpieri
Valentina Serpieri
FDFulvio D’aBrusco
Fulvio D’aBrusco
JDJennifer C Dempsey
Jennifer C Dempsey
YCYong-Han Hank Cheng
Yong-Han Hank Cheng
FAFilippo Arrigoni
Filippo Arrigoni
EVEnza Maria Valente
Enza Maria Valente
Background: Joubert syndrome (JS) is a recessively inherited ciliopathy characterised by congenital ocular motor apraxia (COMA), developmental delay (DD), intellectual disability, ataxia, multiorgan involvement, and a unique cerebellar and brainstem malformation. Over 40 JS-associated genes are known with a diagnostic yield of 60%–75%.In 2018, we reported homozygous hypomorphic missense variants of the SUFU gene in two families with mild JS. Recently, heterozygous truncating SUFU variants were identified in families with dominantly inherited COMA, occasionally associated with mild DD and subtle cerebellar anomalies.Methods: We reanalysed next generation sequencing (NGS) data in two cohorts comprising 1097 probands referred for genetic testing of JS genes.Results: Heterozygous truncating and splice-site SUFU variants were detected in 22 patients from 17 families (1.5%) with strong male prevalence (86%), and in 8 asymptomatic parents. Patients presented with COMA, hypotonia, ataxia and mild DD, and only a third manifested intellectual disability of variable severity. Brain MRI showed consistent findings characterised by vermis hypoplasia, superior cerebellar dysplasia and subtle-to-mild abnormalities of the superior cerebellar peduncles. The same pattern was observed in two out of three tested asymptomatic parents.Conclusion: Heterozygous truncating or splice-site SUFU variants cause a novel neurodevelopmental syndrome encompassing COMA and mild JS, which likely represent overlapping entities. Variants can arise de novo or be inherited from a healthy parent, representing the first cause of JS with dominant inheritance and reduced penetrance. Awareness of this condition will increase the diagnostic yield of JS genetic testing, and allow appropriate counselling about prognosis, medical monitoring and recurrence risk.

1 March 2021 in European Journal of Paediatric Neurology
Verified
Journal Article
Closed access
TGThea Giacomini
Thea Giacomini
SNSara Nuovo
Sara Nuovo
GZGinevra Zanni
Ginevra Zanni
MMMaria Margherita Mancardi
Maria Margherita Mancardi
RCRaffaella Cusmai
Raffaella Cusmai
LPLivia Pisciotta
Livia Pisciotta